Inhibrx Biosciences (INBX) Current Assets (2023 - 2025)
Historic Current Assets for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $161.4 million.
- Inhibrx Biosciences' Current Assets fell 2218.55% to $161.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.4 million, marking a year-over-year decrease of 2218.55%. This contributed to the annual value of $160.4 million for FY2024, which is 4569.37% down from last year.
- As of Q3 2025, Inhibrx Biosciences' Current Assets stood at $161.4 million, which was down 2218.55% from $194.0 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Current Assets ranged from a high of $295.4 million in Q4 2023 and a low of $160.4 million during Q4 2024
- Moreover, its 3-year median value for Current Assets was $207.4 million (2024), whereas its average is $212.0 million.
- Its Current Assets has fluctuated over the past 5 years, first crashed by 4569.37% in 2024, then tumbled by 1986.85% in 2025.
- Inhibrx Biosciences' Current Assets (Quarter) stood at $295.4 million in 2023, then tumbled by 45.69% to $160.4 million in 2024, then grew by 0.64% to $161.4 million in 2025.
- Its Current Assets stands at $161.4 million for Q3 2025, versus $194.0 million for Q2 2025 and $223.4 million for Q1 2025.